QV
Quintus Ventures
Venture CapitalQuietEarly-stage, seed-stage investments in US and European Life Sciences, Software, and Robotics.
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Quintus Ventures.
Investment Thesis & Strategy
Quintus Ventures invests in early-stage and seed-stage companies in the Life Sciences, Software, and Robotics sectors across the US and Europe. They seek to partner with innovative companies with strong growth potential.
Investment Activity
Deals per year over the last 3 years
1
20213
20223
2023Portfolio Companies
Selected investments from their portfolio of 4 companies
R
Replay
Biotech · Series A, 2023
E
Enveda Biosciences
Biotech · Series B, 2023
I
Inceptive
Biotech · Series A, 2023
C
Cellino
Biotech · Series A, 2022
A
Aitia
Biotech · Series A, 2022
V
VantAI
Biotech · Series A, 2022
D
DeepCure
Biotech · Series A, 2021
Frequently Asked Questions
Quintus Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
ARCH Venture Partners
Chicago, United States · 340 deals
Pritzker Group Venture Capital
Chicago, United States · 210 deals
Lightbank
Chicago, United States · 150 deals
Chicago Ventures
Chicago, United States · 135 deals
Hyde Park Venture Partners
Chicago, United States · 131 deals
Second Century Ventures
Chicago, United States · 128 deals